Announcement of the resolution of the first holder meeting of the 2024 employee shareholding plan.
Material for the first interim shareholder meeting in 2024.
Announcement Regarding the Company's First Stock Repurchase through Centralized Competitive Trading Method.
Report on Repurchasing Shares by means of Centralized Bidding Trading
Progress announcement regarding providing guarantees for subsidiary.
Announcement regarding the top ten shareholders and the top ten shareholders with unlimited sales conditions, on the matter of repurchasing stocks.
Announcement of Resolutions of the Fifth Meeting of the Sixth Board of Directors.
Announcement on the plan of repurchasing shares through centralized bidding trade method.
Legal opinion of Deheng (Kunming) Law Firm on the achievement of the first release of restrictions on the grant of the third phase of the restricted stock incentive plan of Yunnan Jianzhijia Health-Chain Pharmaceutical Chain Group Co., Ltd. in 2021.
Announcement on the First Release of Restricted Stock Incentive Plan for 2021 and Unlocking of Restricted Stocks in the Third Phase.
Announcement on the Progress of Establishing a Wholly-Owned Subsidiary for Foreign Investment
Announcement Regarding Additional Pledging of Shares by the Actual Controller of the Company
Progress announcement regarding providing guarantees for subsidiary.
Announcement regarding the completion of industrial and commercial change registration and issuance of business license.
Announcement of the resolution of the fourth meeting of the sixth board of directors.
Announcement of the resolution of the fourth meeting of the sixth board of supervisors.
Announcement regarding the adjustment of the quantity and price of restricted stocks in the company's 2024 stock incentive plan and the granting of restricted stocks to incentive recipients.
Legal opinion of Deheng (Kunming) Law Firm on the adjustment and award of restricted stocks incentive plan of Yunnan Jianzhijia Health-Chain Group Co., Ltd. in 2024.
Supervisory Committee's verification opinion on Yunnan Jianzhijia Health-Chain Pharmaceutical Chain Group Co., Ltd.
Announcement on adjusting the number and repurchase price of the first restricted stock incentive plan granted in 2021 and repurchasing and canceling a portion of the restricted stocks.
No Data